New patent for the drug Alnylam Pharms GIVLAARI – DrugPatentWatch
Annual Drug Patent Expiration for GIVLAARI
Givlaari is a drug marketed by Alnylam Pharms Inc and included in one NDA. It is available from a single supplier. There are fourteen patents protecting this drug.
This drug has three hundred and ninety-three patent family members in forty-two countries.
The generic ingredient in GIVLAARI is givosiran sodium. One registered supplier for this compound. Additional details are available on the givosiran sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug GIVLAARI Alnylam Pharms
